Home > National Drug Code (NDC) > Theophylline Extended Release

Theophylline Extended Release - 0615-2503-39 - (Theophylline, anhydrous)

Alphabetical Index


Drug Information of Theophylline Extended Release

Product NDC: 0615-2503
Proprietary Name: Theophylline Extended Release
Non Proprietary Name: Theophylline, anhydrous
Active Ingredient(s): 200    mg/1 & nbsp;   Theophylline, anhydrous
Administration Route(s): ORAL
Dosage Form(s): TABLET, EXTENDED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of Theophylline Extended Release

Product NDC: 0615-2503
Labeler Name: NCS HealthCare of KY, Inc dba Vangard Labs
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA089808
Marketing Category: ANDA
Start Marketing Date: 19900430

Package Information of Theophylline Extended Release

Package NDC: 0615-2503-39
Package Description: 30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0615-2503-39)

NDC Information of Theophylline Extended Release

NDC Code 0615-2503-39
Proprietary Name Theophylline Extended Release
Package Description 30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0615-2503-39)
Product NDC 0615-2503
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Theophylline, anhydrous
Dosage Form Name TABLET, EXTENDED RELEASE
Route Name ORAL
Start Marketing Date 19900430
Marketing Category Name ANDA
Labeler Name NCS HealthCare of KY, Inc dba Vangard Labs
Substance Name THEOPHYLLINE
Strength Number 200
Strength Unit mg/1
Pharmaceutical Classes Methylxanthine [EPC],Xanthines [Chemical/Ingredient]

Complete Information of Theophylline Extended Release


General Information